FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

Decision ensures continued patient access to VENDAJE® and VENDAJE AC® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused ...

Savannah-based Corstrata recently celebrated a decade of service. The company provides nurses specially trained in advanced wound care to work remotely to bridge a gap.

Patients with hospital-acquired Stage IV bedsores require acute hospitalization and early surgical debridement, clinitron beds, medical optimization, wound preparation, and reconstructive surgery.” — ...

Rising prevalence of chronic wounds, diabetic foot ulcers, and pressure injuries, along with increasing adoption of portable wound care technologies, is driving growth in the Negative Pressure Wound ...

Federal regulators created fresh confusion around a controversial subset of wound care products during a 10-day period in ...

Lisa Farris worried that a nasty infection from recent liposuction and a tummy tuck was rapidly getting worse. So she phoned ...

Adventist Health is pleased to welcome Hector De Jesus, MD, to the Adventist Health Bakersfield Wound Care Center, where he will provide specialized evaluation and treatment for chronic and complex ...